Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2023

Investments, Debt and Equity Securities [Abstract]

The following table summarizes, by major security type, our cash, cash equivalents, restricted cash, and marketable securities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy (in millions):


	December 31, 2022		March 31, 2023
	Total Estimated Fair Value		Cost or Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Total Estimated Fair Value
Cash	$	10,666	$	10,968	$	—	$	—	$	10,968
Level 1 securities:
Money market funds	27,899		35,861		—		—		35,861
Equity securities (1)	3,709								3,231
Level 2 securities:
Foreign government and agency securities	535		28		—		(1)		27
U.S. government and agency securities	2,146		2,341		1		(124)		2,218
Corporate debt securities	22,627		10,193		—		(384)		9,809
Asset-backed securities	2,572		2,572		—		(118)		2,454
Other fixed income securities	237		237		—		(9)		228

	$	70,391	$	62,200	$	1	$	(636)	$	64,796
Less: Restricted cash, cash equivalents, and marketable securities (2)	(365)								(391)
Total cash, cash equivalents, and marketable securities	$	70,026							$	64,405

___________________

(1)The related unrealized gain (loss) recorded in “Other income (expense), net” was $(8.1) billion and $(479) million in Q1 2022 and Q1 2023.

(2)We are required to pledge or otherwise restrict a portion of our cash, cash equivalents, and marketable fixed income securities primarily as collateral for real estate, amounts due to third-party sellers in certain jurisdictions, debt, and standby and trade letters of credit. We classify cash, cash equivalents, and marketable fixed income securities with use restrictions of less than twelve months as “Accounts receivable, net and other” and of twelve months or longer as non-current “Other assets” on our consolidated balance sheets. See “Note 4 — Commitments and Contingencies.”

Investments Classified by Contractual Maturity Date

The following table summarizes the remaining contractual maturities of our cash equivalents and marketable fixed income securities as of March 31, 2023 (in millions):


	Amortized Cost		Estimated Fair Value
Due within one year	$	41,857	$	41,801
Due after one year through five years	7,130		6,675
Due after five years through ten years	594		562
Due after ten years	1,651		1,559
Total	$	51,232	$	50,597

Consolidated Statements of Cash Flow Reconciliation - Cash and Cash Equivalents

The following table provides a reconciliation of the amount of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets to the total of the same such amounts shown in the consolidated statements of cash flows (in millions):


	December 31, 2022		March 31, 2023
Cash and cash equivalents	$	53,888	$	49,343
Restricted cash included in accounts receivable, net and other	358		377
Restricted cash included in other assets	7		14
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	$	54,253	$	49,734

Consolidated Statements of Cash Flow Reconciliation - Restricted Cash


	December 31, 2022		March 31, 2023
Cash and cash equivalents	$	53,888	$	49,343
Restricted cash included in accounts receivable, net and other	358		377
Restricted cash included in other assets	7		14
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	$	54,253	$	49,734